期刊文献+

TRAIL诱导白血病细胞凋亡的分子机制研究 被引量:8

MOLECULAR MECHANISM OF APOPTOSIS OF LEUKAMIC CELLS INDUCED BY SOLUBLE TRAIL
下载PDF
导出
摘要 目的 检测TRAIL引起的T淋巴白血病细胞凋亡及与之相关的蛋白和信号通路 ,为探索T淋巴细胞凋亡分子机制打下基础 ,为相关肿瘤的治疗提供依据。方法 用TRAIL( 1μg/ml)刺激Jurkat细胞 3 6h以诱导细胞发生凋亡 ,用流式细胞术和MTS比色法检测细胞存活率 ,计算细胞凋亡率 ;用免疫印迹 (Westernblot)检测NF κB的表达和胱天肽酶 (caspase) 3、cas pase 8的变化。 结果 TRAIL能诱导Jurkat细胞凋亡并伴随NF κB表达增加及caspase 3和caspase 8的活化。 结论 TRAIL诱导的T淋巴白血病细胞凋亡的分子机制涉及NF κB及caspase 3、caspase 8,为TRAIL用于治疗白血病提供实验基础。 S Objective: To investigate the signal pathway and expression of related proteins in apoptosis of T lymphocyte (leukemia) induced by sTRAIL, providing a novel insight and information in the apoptosis signaling pathways induced by TRAIL and an important implication for the clinic therapy of T-lymphocyte leukemia. Methods: Jurkat cells treated with TRAIL (1 μg/ml) for 36 h were used to detect the viability with MTS assay and Flow Cytometry, and to detect caspase-8, caspase-3 and NF-κB expression with Western blot. Results: TRAIL could induce apoptosis of Jurkat cells with activation of caspase-8, caspase-3 and increasement of NF-κB expression. Conclusions: Molecular mechanism of apoptosis of T-lymphocyte leukemia induced by TRAIL may involve caspase-8, caspase-3 and NF-κB may be involved in signal pathways in Jurkat cells treated by TRAIL.
出处 《实用临床医药杂志》 CAS 2004年第3期36-40,共5页 Journal of Clinical Medicine in Practice
关键词 白血病 TRAIL 细胞凋亡 NF-κB 免疫印迹 流式细胞术 leukemia TRAIL apoptosis NF-κB western blot flow cytometry
  • 相关文献

参考文献16

  • 1Sheridan J P, Marsters S A, Pitti R M, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors[J]. Science, 1997, 277: 818.
  • 2程宏,刘彦信,张锦春,刘士廉,郑德先.CD3ε和5-氟尿嘧啶在T淋巴细胞凋亡中的协同作用及P53的表达[J].中华医学杂志,2003,83(22):1962-1967. 被引量:4
  • 3Wu X X, Kakehi Y, Mizutani Y, et al. Activation of caspase-3 inrenal cell carcinoma cells by anthracyclines or 5-fluroruracil[J]. J Oncol, 2001, 19: 19.
  • 4Wiley S R, Schooley K, Smolak P J, et al. Identification and characterization of new member of the TNF family that induces apoptosis[J]. Immunity, 1995, 3(6): 673.
  • 5Jeremias I, Herr I, Boehlet T, et al. TRAIL/Apo-2-ligand induced apoptosis in human T cells[J]. Eur J Immunol, 1998, 28: 143.
  • 6李宁丽,路丽明,沈佰华,刘莉莉,王利,余奇文,张冬青.重组人可溶性TRAIL分子诱导细胞凋亡机理探讨[J].上海第二医科大学学报,2003,23(1):10-14. 被引量:8
  • 7Marsters S A, Pitti R A, Sheridan J P, et al. Control of apoptosis signaling by Apo2 ligand[J]. Recent Prog Horm Res, 1999, 54: 225.
  • 8Liu Z, Xu X, Hsu H C, et al. CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis[J]. J Clin Invest, 2003, 112: 1315.
  • 9Walczak H, Krammer P H. The CD95(APO1/Fas) and the TRAIL(APO2L) apoptosis systems[J]. Exp Cell Res, 2000, 256: 58.
  • 10Griffith T S, Lynch D H. TRAIL: a molecule with multiple receptors and control mechanisms[J]. Curr Opin Immunol, 1998, 10: 559.

二级参考文献25

  • 1Wiley SR, Schooley K, Smolak PJ,et al. Identification and characterization of a new member of the TNF family that induced apoptosis[J].Immunity,1995,3:672-682.
  • 2Mariant SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage[J]. Eur J Immunol, 1998,28:973-982.
  • 3Jeremias I, Herr I, Boehlet T, et al.TRAIL/Apo-2-ligand induced apoptosis in human T cells[J].Eur J Immunol, 1998,28:143-152.
  • 4MacFarlane M, Ahmad M, Srinivasula SM, et al. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL[J]. J Biol Chem,1997,272:25417 25420.
  • 5Degli Esposti MA, Smolak PJ,Walczak H, et al. Cloning and characterization of TRAIL-R3,a vovel member of the emerging TRAIL receptor family[J].J Exp Med,1997,186:1165-1172.
  • 6Schneider P, Bodmer JL, Thome M, et al. Characterization of two receptors for TRAIL[J].FEBS Lett,1997,416:329-330.
  • 7Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family[J]. J Biol Chem,1996,271:12687-12690.
  • 8Walczak H, Miller RE, Ariail K, et al.Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo[J].Nature Med,1999,5(2):157-163.
  • 9Tanaka S, Sugimachi K, Shirabe K,et al. Expression and anti-tumor effects of Trail in human cholangiocarcinoma[J]. Hepatology,2000,32(3):523-527.
  • 10de Aos I, Metzger MH, Exley M, et al. Tyrosine phosphorylation of the CD3ε subunit of the T cell antigen receptor mediates enhanced association with phosphatidylinositol 3-kinase in Jurkat T cells. J Biol Chem, 1997, 272: 25310-25318.

共引文献9

同被引文献84

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部